Expression Genetics, Inc Company Profile

04:35 EDT 19th March 2018 | BioPortfolio

An Alabama-based specialty biopharmaceutical company developing safe and efficient polymeric delivery systems to be used to create products for treatment of human diseases. Our delivery vehicles, based on a synthetic biocompatible polymeric system can be used to deliver therapeutic genes and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking. Unique polymer chemistry and formulation strategies, designed to overcome delivery barriers, are the distinguishing characteristics of EGEN’s proprietary technology, and differ substantially from other approaches. The lead product based on our TheraPlas™ technology is being evaluated in a Phase I clinical trial for treatment of ovarian cancer.


2215 Mock Road
United States of America


Phone: 1.256.512.0077
Fax: 1.256.512.0988

News Articles [746 Associated News Articles listed on BioPortfolio]

Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience

The post Oxford Genetics Licenses SnapFast™ Expression Vectors to Twist Bioscience appeared first on SynBioBeta.

Oxford Genetics Licenses Expression Vectors To CA-Based Twist Bioscience

NewsOxford will supply Twist with its SnapFast technology platform to provide a broad range of application-specific expression vectors. which will be used to clone synthesized DNA.

Myriad Genetics announces new data on EndoPredict test at 2017 San Antonio Breast Cancer Symposium

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict are being featured at the 2017 San Antonio Breast Canc...

10x Genomics Announces the Addition of Unbiased Gene Expression and B-cell Repertoire to the ...

-- New products for profiling adaptive immunity will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL – Read more...

Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal

microRNAs (miRNAs) are short non-coding RNAs that fine-tune gene expression. The aberrant expression of miRNAs is associated with many diseases and they have both therapeutic and biomarker potential. ...

Nazneen Rahman: In tune with genetics

bmj;359/oct18_4/j4732/FAF1faDuncan SmithBiographyNazneen Rahman is professor of human genetics at the Institute of Cancer Research in London and head of the Cancer Genetics Unit at the Royal Marsden.....

A New Edition of Genetics in Medicine Is Now Available

Genetics in Medicine (vol. 19, no. 5, 2017) is available online by subscription only. Articles include: “Diagnostic Cytogenetic Testing Following Positive Noninvasive Prenatal Screening Results...

Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Expression [Zenith Medicosm SL]

Drug Facts

Expression [Zenith Medicosm SL]

Drug Facts

Esika [Ventura Corporation LTD.]


Retin-a micro [Ortho-McNeil Pharmaceuticals]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

Retin-a micro [Physicians Total Care, Inc.]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

PubMed Articles [3118 Associated PubMed Articles listed on BioPortfolio]

Big Strides in Cellular MicroRNA Expression.

A lack of knowledge of the cellular origin of miRNAs has greatly confounded functional and biomarkers studies. Recently, three studies characterized miRNA expression patterns across >78 human cell typ...

The regulation of tetraspanin 8 gene expression-A potential new mechanism in the pathogenesis of bipolar disorder.

In a previous study, we identified the single nucleotide polymorphism (SNP) rs4500567, located in the upstream region of tetraspanin 8 (TSPAN8), to be associated with bipolar disorder (BD). Due to its...

Introduction to behavioral phenotypes in medical genetics.

Modularity Facilitates Flexible Tuning of Plastic and Evolutionary Gene Expression Responses During Early Divergence.

Gene expression changes have been recognized as important drivers of adaptation to changing environmental conditions. Little is known about the relative roles of plastic and evolutionary responses in ...

Medical genetics and genomic medicine in the United States. Part 2: Reproductive genetics, newborn screening, genetic counseling, training, and registries.

Review of genetics in the United States with emphasis on the prenatal, metabolic, genetic counseling, and training aspects of the field.

Clinical Trials [1693 Associated Clinical Trials listed on BioPortfolio]

Genetics of Women With Lobular Carcinoma in Situ of the Breast

RATIONALE: Gathering information about genetic changes in patients with lobular carcinoma in situ of the breast may help doctors learn more about the disease and find better methods of tre...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetic Studies in Liver Cancer Patients

Hepatocellular carcinoma (HCC) is one the most common malignancies in the world, especially in sub-Saharan Africa and Southeast Asia. Since 1984, it has been the leading cause of cancer de...

Companies [313 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Oxford Expression Technologies

Oxford Expression Technologies is a world-renowned centre of excellence for baculovirus protein expression. We provide protein expression products, services and consultancy to many global pharmaceutic...

More Information about "Expression Genetics, Inc" on BioPortfolio

We have published hundreds of Expression Genetics, Inc news stories on BioPortfolio along with dozens of Expression Genetics, Inc Clinical Trials and PubMed Articles about Expression Genetics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Expression Genetics, Inc Companies in our database. You can also find out about relevant Expression Genetics, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record